LEXARIA BIOSCIENCE CORP.
Profile
Company Names
LEXARIA BIOSCIENCE CORP.
Addresses
100 - 740 MCCURDY ROAD, KELOWNA, A1 V1X 2P7
156 VALLEYVIEW ROAD, KELOWNA, A1 V1X 3M4
SUITE 950, 1130 WEST PENDER STREET, VANCOUVER, A1 V6E 4A4
Phone Numbers
250-765-6424
604-602-1675
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS, OTHER
Year Incorporated:
> 5 years ago
State Incorporated:
NEVADA
Total Amount Raised:
$22,549,644.00
Number of Funding Rounds:
14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2025-12-16
$3,500,004.00
$3,500,004.00
$0.00
13
2025-09-29
$4,000,000.00
$4,000,000.00
$0.00
12
2024-10-16
$5,000,000.00
$5,000,000.00
$0.00
11
2024-04-30
$364,629.00
$364,629.00
$0.00
10
2024-02-16
$3,600,003.00
$3,600,003.00
$0.00
9
2023-10-03
$1,569,780.00
$1,569,780.00
$0.00
8
2021-12-16
$1,200,000.00
$1,200,000.00
$0.00
Equity
7
2021-07-27
$85,000.00
$85,000.00
$0.00
Equity
6
2020-06-30
$100,000.00
$100,000.00
$0.00
Equity
5
2020-05-06
$2,039,228.00
$2,039,228.00
$0.00
Equity
4
2019-11-13
$492,500.00
$2,357,594.00
$1,865,094.00
Equity
3
2019-11-05
$180,000.00
$180,000.00
$0.00
2
2018-10-31
$310,000.00
$310,000.00
$0.00
Equity
1
2016-08-31
$108,500.00
$108,500.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NICHOLAS
W.
BAXTER
DIRECTOR
BAL
BHULLAR
DIRECTOR
CHRIS
BUNKA
EXECUTIVE OFFICER, DIRECTOR
RICHARD
CHRISTOPHER
EXECUTIVE OFFICER, DIRECTOR
BRIAN
QUIGLEY
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$5,000,001 - $25,000,000
2025-12-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$5,000,001 - $25,000,000
2025-09-29
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$5,000,001 - $25,000,000
2024-10-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2021-12-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
$1 - $1,000,000
Equity
2021-07-27

